Maiden Pharma hopes to reopen plant as Indian lab clears syrups suspected by WHO in Gambia deaths

Indian health authorities halted production at Maiden's main factory in Sonepat near New Delhi in October after a WHO report said the company's cough and cold syrups might be connected to the deaths of 69 children in Gambia this year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9qjkwHo
via IFTTT